Trueblood Wealth Management’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,304
Closed -$243K 262
2026
Q1
$243K Sell
1,304
-996
-43% -$206K 0.1% 229
2025
Q4
$609K Sell
2,300
-10
-0.4% -$2.48K 0.24% 129
2025
Q3
$548K Sell
2,310
-936
-29% -$236K 0.21% 137
2025
Q2
$885K Buy
3,246
+21
+0.7% +$5.61K 0.37% 94
2025
Q1
$866K Buy
3,225
+530
+20% +$165K 0.4% 86
2024
Q4
$901K Buy
2,695
+319
+13% +$102K 0.44% 71
2024
Q3
$650K Buy
2,376
+49
+2% +$12.6K 0.33% 98
2024
Q2
$598K Buy
2,327
+94
+4% +$25.2K 0.34% 97
2024
Q1
$673K Buy
2,233
+450
+25% +$130K 0.39% 85
2023
Q4
$469K Buy
+1,783
New +$404K 0.29% 107

Other funds holding CRM

Trueblood Wealth Management's CRM Position: Q2 2026 in Review

Trueblood Wealth Management sold out of Salesforce (CRM) in Q2 2026, closing a stake of 1,304 shares — an estimated $243K sold.

Trueblood Wealth Management first reported a position in CRM in Q4 2023 and held it in 10 quarters. The position peaked at $901K in Q4 2024. 2,472 funds tracked by Wall St. Rank hold CRM as of Q2 2026.

  • Trueblood Wealth Management reported no remaining Salesforce position as of Q2 2026 after selling out during the quarter.
  • Trueblood Wealth Management sold 1,304 Salesforce shares in Q2 2026, an estimated $243K.
  • Trueblood Wealth Management first reported a position in Salesforce in Q4 2023 and held it in 10 quarters.
  • Trueblood Wealth Management's Salesforce position peaked at $901K in Q4 2024.
  • 2,472 funds tracked by Wall St. Rank held Salesforce as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.